Five days after tumor cell injections, treatments with the well-characterized 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) nanoliposomes2, 33, 34 carrying either non-targeting siRNA (siCTRL) or YAP1 siRNA alone, or in conjunction with platelet transfusions were started and repeated twice weekly for 4 weeks. Here, YAP1 is linked to neoplasm.